HempStreet

HempStreet is India's pioneering research to retail venture in the ayurvedic cannabis sector. The company collaborates with leading scientists to conduct R&D on safe cannabis-based medication, which is distributed through a network of over 60,000 medical practitioners and 220 clinics across India. With a focus on responsible cannabis usage, particularly for pain relief, HempStreet aims to serve a potential patient base of over 35 million individuals. As the first major player in this emerging sector, the company has voluntarily taken on the role of defining industry standards, encompassing world-class research, supply chain tracking, and responsible, regulated formulation, and dispensing of cannabis-based medication.

HempStreet is dedicated to sourcing from small farmers post obtaining licenses for cannabis contract farming, envisioning cannabis as a lifeline for them. Its vision is to become the leading global producer of cannabis medicines, offering researched herbal cannabis-based solutions for chronic pain relief. Additionally, the company aims to provide a sustainable and economical response to the growing pain epidemic, incorporating blockchain integration to track every manufactured pill, mitigating potential abuse.

Founded in 2019 and headquartered in India, HempStreet secured a significant INR83.00M in Seed Round investment on 28 November 2023, with notable investors including Andre Rodrigues, Carl Waahlin, and Abhishek Mohan.